Science & Technology

A pathway that enables embryonic cells to develop into different organs can be reactivated by cancer cells. A cyclic peptide has been found that can block the activation of this pathway, and is also less likely to trigger resistance in cancer cells.

The assistant professor of earth and environmental sciences has been selected as the recipient of the 2017 Mineralogical Society of America Award, a major honor in the field.

Back in 1959, early in his career as a Kodak chemist, Donald Batesky was lead author of a paper in the Journal of Organic Chemistry. Now the 85-year-old research associate is lead author again, for discovering a technique that had been overlooked for years.

What if researchers could find a way to bypass damaged areas of the brain to maintain the flow of information? That is the problem postdoctoral fellow Kevin Mazurek is working to solve.

The common fruit fly is often deemed an annoying household pest. But these tiny insects are a boon to researchers. Rochester biologist John Jaenike has co-authored the first comprehensive guide to fruit flies published in nearly a century.

An expert in human-computer interaction and a pioneer in developing apps that help people hone their speaking and social skills, Hoque continues to apply lessons of resiliency he learned as an undergraduate.

Optics professor Xi-Cheng Zhang has worked for nearly a decade to solve a scientific puzzle.

Inspired by Austin's South by Southwest conference, the organizers of this year's event partnered with RIT and the City of Rochester to highlight the region as a source for innovation.

Biologist Amanda Larracuente and her team are the first to successfully sequence the firefly genome.

Governor Andrew M. Cuomo yesterday announced $20 million in state support for the creation of a Rochester Data Science Consortium at the University of Rochester, with Harris Corporation as the consortium’s first partner.

Krystel Huxlin has developed rigorous visual training that can restore some of the basic vision lost to traumatic brain injury, stroke, or a tumor. Here Huxlin discusses how this therapy teaches undamaged parts of the brain to take over.

Researchers have identified a protein that is required for cell death after undergoing chemotherapy—at least, it appears, in male mice.